Search

Your search keyword '"Markivskyy A"' showing total 2 results
Start Over Author "Markivskyy A" Publication Year Range Last 10 years
2 results on '"Markivskyy A"'

1. Pimasertib (PIM) versus dacarbazine (DTIC) in patients (pts) with cutaneous NRAS melanoma: a controlled, open-label phase II trial with crossover

Author

Lebbe, C., primary, Dutriaux, C., additional, Lesimple, T., additional, Kruit, W., additional, Kerger, J., additional, Thomas, L., additional, Guillot, B., additional, de Braud, F., additional, Garbe, C., additional, Grob, J.J., additional, Loquai, C., additional, Ferraresi, V., additional, Robert, C., additional, Vasey, P., additional, Conry, R., additional, Isaacs, R., additional, Espinosa, E., additional, Schueler, A., additional, Markivskyy, A., additional, and Dreno, B., additional

Published
2016
Full Text
View/download PDF

2. Pimasertib (PIM) versus dacarbazine (DTIC) in patients (pts) with cutaneous NRAS melanoma: a controlled, open-label phase II trial with crossover

Author

Paul Vasey, F. de Braud, Carmen Loquai, Luc Thomas, Enrique Espinosa, Wim H. J. Kruit, Robert M. Conry, R. Isaacs, Caroline Dutriaux, Virginia Ferraresi, Brigitte Dréno, Joseph Kerger, Thierry Lesimple, A. Markivskyy, Claus Garbe, J.-J. Grob, Armin Schueler, C. Robert, Céleste Lebbé, and Bernard Guillot

Subjects
0301 basic medicine, Oncology, Neuroblastoma RAS viral oncogene homolog, medicine.medical_specialty, business.industry, Melanoma, Hematology, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Pimasertib, In patient, Dacarbazine - DTIC, Open label, business
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results